StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO)

StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note released on Saturday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

Shares of NASDAQ:TTOO opened at $0.18 on Friday. T2 Biosystems has a 12-month low of $0.06 and a 12-month high of $6.80. The business has a 50 day moving average of $0.27 and a 200-day moving average of $1.27.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.